Amgen Stock Slouches As Lilly Doubts Its Weight-Loss Approach
Amgen (AMGN) stock slouched Wednesday following a fourth-quarter beat as analysts' zeroed in on the company's experimental weight-loss drugs and a burgeoning battle with Eli Lilly (LLY).
X
The biotech giant has two drugs in…